Organon & Co banner

Organon & Co
NYSE:OGN

Watchlist Manager
Organon & Co Logo
Organon & Co
NYSE:OGN
Watchlist
Price: 7.2 USD -1.23% Market Closed
Market Cap: $1.9B

Profitability Summary

Organon & Co's profitability score is 49/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

49/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

49/100
Profitability
Score
49/100
Profitability
Score

Margins

Earnings Waterfall
Organon & Co

Margins Comparison
Organon & Co Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Organon & Co
NYSE:OGN
1.9B USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
963B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
599.3B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
282.3B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
244.3B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
233.1B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
300.9B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
155.1B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125.7B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Organon & Co Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Organon & Co
NYSE:OGN
1.9B USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
963B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
599.3B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
282.3B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
244.3B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
233.1B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
300.9B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
155.1B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125.7B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Organon & Co

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett